Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Acquisitions (Net)

Cash paid for acquiring businesses, net of cash acquired.

Cronos Group Inc.TSX: CRON.TO

Acquisitions (Net) · Q1 FY2026 · quarter ended Mar 2026

Acquisitions (net) outflow grows to $0

Q1 FY2026 acquisitions (net) was $0, compared with $0 a year earlier. Trailing-twelve-month acquisitions (net) was $2.9M.

Context

  • Acquisitions (net) amounted to 1.9% of revenue in FY2025, down 3.2 pp from a year earlier.
  • Acquisitions (net) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly acquisitions (net) holds near $0 or moves back toward the trailing-twelve-month quarterly average of $724.21K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$2.9M-51.7% YoY
LTMMar 2026
$2.9M— YoY
Acquisitions (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year-51.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Acquisitions (Net) history

USD · from the cash flow

Latest · FY2025
2.9M USD
Year-over-year change
-51.7%

Acquisitions (Net) vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so acquisitions (net) is compared through growth and share of revenue rather than absolute size.
  • Acquisitions (net) amounts to 1.8% of revenue for CRON.TO, versus a peer median of 21.6%.
CRON.TO Competitors
Acquisitions (Net) for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$728.04M CAD+67311.3%—36.8%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$262.46M CAD+26.6%—23.6%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$110.08M CAD-262197.6%—21.6%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$60.02M CAD-26.1%+37.3%4.1%
CRON.TOCronos Group Inc.LTM Mar 2026$2.9M USD——1.8%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$2.07M USD+123.7%—0.2%
Peer median (excluding CRON.TO) —+26.6%+37.3%21.6%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(397.2M)(168.73M)(74.55M)40.02M(9.61M)
Depreciation & Amortization15.4M13.12M8.11M9.34M14.48M
Deferred Income Tax222.22M043.32M00
Stock-Based Compensation10.15M15.12M8.77M8.7M0
Change in Working Capital(2.01M)20.66M(26.47M)(311K)(35.02M)
Accounts Receivables(13.16M)(2.71M)9.21M(2.51M)(26.2M)
Inventory11.57M(7.22M)7.4M7.42M(10.58M)
Accounts Payables(2.37M)(863K)(773K)(7.45M)1.13M
Other Working Capital1.97M31.45M(42.3M)2.24M636.96K
Other Non-Cash Items(2.18M)30.89M(2.01M)(38.9M)56.47M
Operating Cash Flow(153.62M)(88.95M)(42.84M)18.84M26.32M
Capital Expenditures(12.26M)(5.03M)(3.42M)(13.15M)(26.17M)
Acquisitions (Net)(1.12M)0724K5.99M2.9M
Purchases of Investments(230M)(271.38M)(608.25M)0(59.44M)
Sales of Investments215.3M268.87M532.84M185.82M5.15M
Other Investing Activities(819K)5.7M18.61M(4.25M)0
Investing Cash Flow(28.9M)(1.84M)(59.5M)175.15M(77.9M)
Debt Repayment00000
Common Stock Issued15.73K0000
Common Stock Repurchased0(2.85M)(1.03M)0(9.91M)
Dividends Paid00000
Other Financing Activities(13.46M)(42.36K)(2.47K)(1.23M)(10.34M)
Financing Cash Flow(13.44M)(2.9M)(1.03M)(1.23M)(20.25M)
Effect of Forex Changes4.91M(28.64M)8.01M(3.25M)(37.24M)
Net Change in Cash(191.05M)(122.33M)(95.35M)189.51M(109.07M)
Free Cash Flow(165.88M)(93.98M)(46.26M)5.69M151.61K

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.